Merrimack Pharmaceuticals

Merrimack initiates Phase 2 clinical study of MM-111
Yahoo/Fly on the Wall
Mon, 07/22/13 - 11:26 am
Merrimack Pharmaceuticals
MM-111
gastric cancer
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Mon, 07/15/13 - 11:58 am
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
3 Horrendous Health-Care Stocks This Week
Motley Fool
Sat, 07/13/13 - 12:02 pm
Merrimack Pharmaceuticals
GTx
Intuitive Surgical
Merrimack Pharma Prices Stock and Convertible Note Issues
Motley Fool
Sat, 07/13/13 - 11:44 am
Merrimack Pharmaceuticals
Biotech Stock Mailbag: 2013 Clinical Trials Calendar
TheStreet.com
Fri, 06/7/13 - 08:41 am
Zerenex
Xoma
Vical
Takeda
sovaprevir
Soluble Ferric Pyrophosphate
Rockwell Medical
Orexigen
MM-398
Merrimack Pharmaceuticals
MannKind
Keryx
GTx
GSK
gevokizumab
enobosarm
Coronado Biosciences
Contrave
CNDO-201
clinical trials
ChemoCentryx
CCX140
Biodel
BIOD-123
Amigal
Amicus Therapeutics
Alnylam
ALN-TTR02
Allovectin
Afrezza
Achillion
ACH-3102
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
The Fly on the Wall
Thu, 05/23/13 - 09:44 am
Merrimack Pharmaceuticals
MM-121
breast cancer
Merrimack lung cancer drug fails goal in one mid-stage trial group
Reuters
Thu, 04/4/13 - 09:22 am
lung cancer
Merrimack Pharmaceuticals
MM-121
non-small cell lung cancer
3 Bio-Pharmaceuticals Insiders Love
Motley Fool
Sun, 03/3/13 - 11:19 am
MannKind
Merrimack Pharmaceuticals
Tesaro
3 Events Biotech Investors Need to Watch in 2013
Motley Fool
Thu, 02/14/13 - 10:28 am
Vical
Allovectin
metastatic melanoma
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
Afrezza
diabetes
MannKind
4 Biotech Stocks With Insider Interest
Motley Fool
Thu, 01/10/13 - 11:30 am
Infinity Pharmaceuticals
Merrimack Pharmaceuticals
Sarepta
Arena Pharmaceuticals
3 Things to Watch at Merrimack
Motley Fool
Sun, 12/30/12 - 12:12 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
MM-121
breast cancer
lung cancer
Does Merrimack Pharmaceuticals Have A Blockbuster Drug With MM-398?
Seeking Alpha
Thu, 12/6/12 - 05:32 pm
Merrimack Pharmaceuticals
MM-398
pancreatic cancer
5 Low-Debt Biotech Stocks Forecasted For Growth
Seeking Alpha
Sat, 09/22/12 - 02:24 pm
Merrimack Pharmaceuticals
Durata Therapeutics
BioSpecifics Technologies
Pain Therapeutics
Acadia
5 High-Growth Biotechnology Stocks That Analysts Strongly Favor
Seeking Alpha
Sat, 08/25/12 - 11:41 am
Pain Therapeutics
Cerus
Zalicus
Merrimack Pharmaceuticals
Cell Therapeutics
Merrimack 2Q loss narrows on drug payments
Yahoo/AP
Sat, 08/11/12 - 11:18 am
Merrimack Pharmaceuticals
earnings
7 Fast Growing Small Cap Biotech Stocks With Analyst Confidence
Seeking Alpha
Fri, 07/6/12 - 11:01 am
Acorda
Cadence Pharmaceuticals
EXACT Sciences
Merrimack Pharmaceuticals
Nektar
Santarus
Threshold Pharmaceuticals
Merrimack IPO Falls Out Of The Gate
Seeking Alpha
Mon, 04/2/12 - 10:41 am
Merrimack Pharmaceuticals
IPOs
IPO Preview: Merrimack Pharmaceuticals
Seeking Alpha
Mon, 01/30/12 - 03:51 pm
IPOs
Merrimack Pharmaceuticals
cancer
Sanofi
MM-121
Merrimack IPO: Repackaging And Refining Chemotherapy
Seeking Alpha
Fri, 01/27/12 - 10:15 am
IPOs
Merrimack Pharmaceuticals
chemotherapy
5 promising pancreatic cancer drugs
Fierce Biotech
Thu, 10/13/11 - 01:23 pm
Amgen
Takeda
Ganitumab
KAEL-GemVax
GV1001
HyperAcute Pancreas
NewLink Genetics
GI-4000
GlobeImmune
MM-398
Merrimack Pharmaceuticals
pancreatic cancer

Pages